Cargando…
Prospective cohort study reveals MMP-9, a neuroplasticity regulator, as a prediction marker of cochlear implantation outcome in prelingual deafness treatment
Because of vast variability of cochlear implantation outcomes in prelingual deafness treatment, identification of good and poor performers remains a challenging task. To address this issue, we investigated genetic variants of matrix metalloproteinase 9 (MMP9) and brain-derived neurotrophic factor (B...
Autores principales: | Matusiak, Monika, Oziębło, Dominika, Ołdak, Monika, Rejmak, Emilia, Kaczmarek, Leszek, Skarżyński, Piotr Henryk, Skarżyński, Henryk |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9262127/ https://www.ncbi.nlm.nih.gov/pubmed/35061219 http://dx.doi.org/10.1007/s12035-022-02732-7 |
Ejemplares similares
-
Functional Polymorphism of MMP9 and BDNF as Potential Biomarker of Auditory Neuroplasticity in Prelingual Deafness Treatment With Cochlear Implantation—A Retrospective Cohort Analysis
por: Matusiak, Monika, et al.
Publicado: (2021) -
MMP-9 plasma level as biomarker of cochlear implantation outcome in cohort study of deaf children
por: Matusiak, Monika, et al.
Publicado: (2023) -
Longitudinal Changes in BDNF and MMP-9 Protein Plasma Levels in Children after Cochlear Implantation
por: Matusiak, Monika, et al.
Publicado: (2023) -
Cochlear Implantation Outcome in Children with DFNB1 locus Pathogenic Variants
por: Oziębło, Dominika, et al.
Publicado: (2020) -
Searching for the Molecular Basis of Partial Deafness
por: Oziębło, Dominika, et al.
Publicado: (2022)